Peripheral dermal fibroblasts (DF) from a healthy 56 year old female were obtained from the Centre for Healthy Brain Ageing (CHeBA) Biobank, University of New South Wales, under the material transfer agreement with the University of Wollongong. DFs were reprogrammed via mRNA-delivered transcription factors into induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed to be pluripotent, capable of three germ layer differentiation and are thus a useful resource for creating iPSC-derived healthy human cells of any lineage.
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A B S T R A C T
Peripheral dermal fibroblasts (DF) from a healthy 56 year old female were obtained from the Centre for Healthy Brain Ageing (CHeBA) Biobank, University of New South Wales, under the material transfer agreement with the University of Wollongong. DFs were reprogrammed via mRNA-delivered transcription factors into induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed to be pluripotent, capable of three germ layer differentiation and are thus a useful resource for creating iPSC-derived healthy human cells of any lineage.
Resource 
Resource utility
This iPSC line can be used as an age and gender matched healthy control.
Resource details
Dermal fibroblast (DF) samples from a 56 year old healthy female volunteer were obtained from CHeBA Biobank, University of New South Wales. To generate the iPSC line (UOWi001-A, Fig. 1 ), the reprogramming factors Oct4, Sox2, Klf4, c-Myc and Lin28 were delivered via microRNA-Enhanced mRNA Reprogramming Kit (Stemgent, 00-0071) according to the manufacturer's instructions. The first iPSCs appeared after 11 days, with colonies forming within 24 h. Individual colonies (clones) were isolated after 13 days. After 6 passages, we initiated the characterization of clone 8 (UOWi001-A). The iPSC colonies had a characteristic morphology (Fig. 1A) expressed the transcripts for POU5F1 and NANOG, which were not expressed in the original fibroblasts (Fig. 1B) , and a normal karyotype (Fig. 1C) . The iPSC colonies showed widespread expression of the pluripotency markers SSEA-4, Oct4 and Tra-1-60 (Fig. 1D, E, F) . Following the confirmation of UOWi001-A identity via short tandem repeat (STR) profiling (with journal), we assessed the pluripotency potential via the hPSC Scorecard assay. Spontaneous in vitro differentiation via embryoid body formation confirmed the three-germ layer differentiation potential of UOWi001-A (Fig. 1G ).
Materials and methods

Reprogramming of dermal fibroblasts
DF samples from a 56 year old female were obtained from CHeBA Biobank, University of New South Wales. The study was approved by the University of Wollongong Human Ethics Committee (HE 13/299). DFs were cultured in fibroblast medium, consisting of Dulbecco's Modified Eagle Medium F12 (DMEM/F12, ThermoFisher, 12,500-096) supplemented with 10% foetal bovine serum (Interpath SFBS-F) and 1× Non-Essential Amino Acids (ThermoFisher, 11, 140, 050) , at 37°C and 5% CO 2 . Fibroblasts were reprogrammed using Stemgent microRNA-Enhanced mRNA Reprogramming Kit (Stemgent, 00-0071), following the manufacturer's protocol. Prior to reprogramming, Pluriton Reprogramming Medium was conditioned using newborn human foreskin fibroblasts (Globalstem, GSC3006G) as per the reprogramming protocol. Spontaneous iPSC colonies appeared on day 11 and were isolated on day 13 for expansion into individual iPSC lines (clones). Established iPSC clones were maintained in TeSR-E8 (Stemcell Technologies, 05940) on Matrigel-coated (Corning, FAL354277) plates at 37°C in 5% O 2 and were split 1:5 using dispase (1 mg/ml, Stemcell Technologies, 07913) on reaching 60% confluency Table 1 .
Immunofluorescence staining
The iPSCs were cultured on Matrigel-coated glass coverslips in TeSR-E8, fixed with 4% paraformaldehyde for 10 min, permeabilised with 0.05% Triton-X for either 7 or 15 min for Oct4 and SSEA-4 respectively, and blocked with 10% goat serum for 1 h, all at room temperature (ThermoFisher, 16, . Cultures were incubated with primary antibodies (Table 2) or mouse IgG control (ThermoFisher, 10400C) at +4°C for 16 h, followed by secondary antibody incubation for 1 h at room temperature (Table 2) , and nuclear staining with RedDot2 (1:200, Biotium, 40,061-1). For Tra-1-60 live stain (Table 2) , cultures were incubated with TeSR-E8 and Tra-1-60 (4 μg/ml) for 30 min followed by media washing steps. Z-stack images were captured on a confocal microscope (Leica DMI6000B) and acquired using LAS AF (Leica Microsystems).
Karyotyping
The iPSCs were cultured on Matrigel-coated T25 flasks in TeSR-E8 until 60% confluent. Cultures were processed for karyotyping by Sullivan Nicolaides Pathology (Bowen Hills, Australia) at 400 bands per haploid set resolution.
Quantitative polymerase chain reaction (qPCR)
Fibroblast and iPSC cultures were sampled with Tri-Reagent (MRC Gene, TR 118) and RNA was extracted as per manufacturer's instructions. Sample quality was confirmed via Nanodrop (260/ 280 = 1.9-2.0), followed by removal of genomic DNA (Turbo DNAse, ThermoFisher, AM1907) and reverse transcription (Tetro cDNA Synthesis kit, Bioline BIO-65043). The expression of POU5F1 and NANOG was assessed in triplicates via qPCR (SensiFast SYBR, Bioline, BIO-98020) on a LightCycler 480 (Roche), validated through melt curve analysis and normalized to the expression of housekeeper genes GAPDH and HPRT1. The efficiency of each sample was determined using LinRegPCR (Ruijter et al., 2009 ) and analysis was performed using the ΔΔCt method.
Pluripotent stem cell scorecard assessment
The iPSC colonies were grown on Matrigel-coated 60 mm dishes for 10 days from single cell passaging in mTeSR1 (Stemcell Technologies, 85, 850) . Colonies were transferred to non-tissue culture treated dishes following dispase incubation. One day after passaging, the iPSC colonies formed spheres and the media was changed from mTeSR1 to DMEM/F12 with 10% foetal bovine serum. After 21 days in suspension, ThermoFisher, 4, 368, 814) . The hPSC Scorecard qPCR (ThermoFisher, 100,019,864) was run as per manufacturer's instruction on a Quantstudio 5 (ThermoFisher) and analysed through the Scorecard application.
